Spectrum Pharmaceuticals
SPPI
$1.03
Share price
0.00%
Change (1 day)
17.05%
Change (1 year)
Categories
Spectrum Pharmaceuticals (SPPI) Fails to deliver data
Key failure to deliver metrics for Spectrum Pharmaceuticals :
- Last SEC data release: 2024-05-14
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: $0.23 M
Failures to deliver for Spectrum Pharmaceuticals (SPPI) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Spectrum Pharmaceuticals (SPPI) - since 2013
Volume in USD (price x number of shares), data since 2013Spectrum Pharmaceuticals (SPPI) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $0.64 M | -92.96% |
| 2022 | $9.13 M | 32.85% |
| 2021 | $6.87 M | 0.68% |
| 2020 | $6.83 M | 135.57% |
| 2019 | $2.89 M | -77.1% |
| 2018 | $12.65 M | 286.72% |
| 2017 | $3.27 M | -4.51% |
| 2016 | $3.42 M | -61.82% |
| 2015 | $8.97 M | -2.72% |
| 2014 | $9.22 M | 42.79% |
| 2013 | $6.46 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $28.5 M | $0.59 B | 🇺🇸 USA |
 Novartis NVS | $20.77 M | $81.53 M | 🇨🇭 Switzerland |
 Pfizer PFE | $13.91 M | $0.31 B | 🇺🇸 USA |
 Abbott Laboratories ABT | $14.63 M | $0.13 B | 🇺🇸 USA |
 Biogen BIIB | $22.83 M | $75.97 M | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.23 B | $0.33 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $17.9 M | $24.11 M | 🇬🇧 UK |
 Seagen
SGEN | N/A | $34.5 M | 🇺🇸 USA |
 Curis CRIS | N/A | $0.94 M | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $0.84 M | $25.76 M | 🇮🇱 Israel |